89 related articles for article (PubMed ID: 7985058)
1. [Familial thrombophilia due to resistance to activated protein C].
Cuevas V; Tortosa JI; Rodríguez C; Alonso JM; García Frade LJ
Sangre (Barc); 1994 Aug; 39(4):283-6. PubMed ID: 7985058
[TBL] [Abstract][Full Text] [Related]
2. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of thrombophilia based on coagulation and genetic studies].
Bałszan-Kowalska I
Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
[TBL] [Abstract][Full Text] [Related]
6. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
8. [Thrombophilia in patients with venous thromboembolism].
Rodríguez Pinto MC; Fernández Urgellés M; Soto Ortega I; García Gala JM; Rosón Porto C; Corte Buelga JR
Sangre (Barc); 1996 Feb; 41(1):37-42. PubMed ID: 8779033
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
[TBL] [Abstract][Full Text] [Related]
10. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism.
Goldenberg N; Kahn SR; Solymoss S
J Clin Oncol; 2003 Nov; 21(22):4194-9. PubMed ID: 14615447
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
12. Resistance to activated protein C: a common inherited cause of venous thrombosis.
Gillespie DL; Carrington LR; Griffin JH; Alving BM
Ann Vasc Surg; 1996 Mar; 10(2):174-7. PubMed ID: 8733870
[TBL] [Abstract][Full Text] [Related]
13. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease.
Glueck CJ; Glueck HI; Greenfield D; Freiberg R; Kahn A; Hamer T; Stroop D; Tracy T
Pediatr Res; 1994 Apr; 35(4 Pt 1):383-8. PubMed ID: 8047373
[TBL] [Abstract][Full Text] [Related]
14. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis.
Glueck CJ; Wang P
Clin Appl Thromb Hemost; 2009 Feb; 15(1):12-8. PubMed ID: 18796459
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
[TBL] [Abstract][Full Text] [Related]
16. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
[TBL] [Abstract][Full Text] [Related]
17. Interaction of heritable and estrogen-induced thrombophilia: possible etiologies for ischemic optic neuropathy and ischemic stroke.
Glueck CJ; Fontaine RN; Wang P
Thromb Haemost; 2001 Feb; 85(2):256-9. PubMed ID: 11246543
[TBL] [Abstract][Full Text] [Related]
18. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study).
Mateo J; Oliver A; Borrell M; Sala N; Fontcuberta J
Thromb Haemost; 1997 Mar; 77(3):444-51. PubMed ID: 9065991
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
Svensson PJ; Zöller B; Dahlbäck B
Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
[TBL] [Abstract][Full Text] [Related]
20. Familial dysfunction of protein S.
Mannucci PM; Valsecchi C; Krachmalnicoff A; Faioni EM; Tripodi A
Thromb Haemost; 1989 Sep; 62(2):763-6. PubMed ID: 2530648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
